What certifications should chemical synthesis companies hold for pharmaceutical work?

When sourcing active pharmaceutical ingredients, intermediates, or synthesized compounds, the certifications held by a chemical synthesis company directly determine whether its products are accepted by pharmaceutical manufacturers, regulatory bodies, and global supply chains. For companies working in pharmaceutical applications, the certification landscape is not just a compliance checkbox — it is the foundation of product safety, batch consistency, and market access.

The pharmaceutical industry operates under one of the most stringent regulatory frameworks of any sector. Every chemical synthesis provider that supplies raw materials, intermediates, or active ingredients must demonstrate compliance with internationally recognized quality standards. Below is a comprehensive breakdown of the certifications every chemical synthesis company should hold for pharmaceutical work, and why they matter.

1. Good Manufacturing Practices (GMP) — The Non-Negotiable Standard

GMP is the single most important certification for any chemical synthesis company serving the pharmaceutical industry. Good Manufacturing Practices are a set of principles that ensure products are consistently produced and controlled according to quality standards. For chemical synthesis, GMP covers raw material control, manufacturing processes, facility hygiene, equipment qualification, documentation, and personnel training.

The most widely recognized GMP framework is the WHO GMP, accepted by regulatory authorities in over 100 countries. Beyond that, manufacturers targeting specific markets must also comply with EU GMP (EudraLex Volume 4) for European markets and US FDA cGMP (21 CFR Parts 210 and 211) for the United States. A custom chemical synthesis provider that holds GMP certification demonstrates its commitment to rigorous quality control at every stage of production.

Companies such as Hangzhou Green Sky Biotechnology Co., Ltd. (Greenskybio) exemplify this commitment. With over 20 years of industry experience, Greenskybio operates under cGMP and GLP standards across its three advanced factories equipped with extraction, concentration, distillation, separation, and spray drying equipment. The company has also passed the Shanghai SGS GMP management system certification, verifying its compliance with international GMP principles.

2. ISO 9001 — The Quality Management System Foundation

ISO 9001 is the global benchmark for quality management systems. It establishes the documentation framework, internal audit programme, management review process, and corrective action system that all other pharmaceutical certifications build upon. For chemical synthesis companies, ISO 9001 certification signals to pharmaceutical buyers that the organization has a robust quality management infrastructure in place.

ISO 9001 is often the fastest certification to achieve — typically 3 to 5 months from gap analysis — and serves as the starting point for companies building their compliance portfolio. It is also a prerequisite for many government tenders and multinational pharmaceutical supplier qualification programs. Greenskybio holds ISO 9001 certification, reinforcing its position as a reliable partner for pharmaceutical-grade chemical synthesis.

3. US FDA Compliance — Gateway to the American Market

For any chemical synthesis company whose products are destined for the United States pharmaceutical market, FDA compliance is essential. While not every intermediate or synthesized compound requires direct FDA approval, understanding and adhering to FDA principles in manufacturing, quality control, and documentation is critical for seamless integration into the US pharmaceutical supply chain.

The US FDA enforces Current Good Manufacturing Practice (cGMP) under 21 CFR Parts 210 and 211. This includes requirements for facility design, equipment validation, batch record keeping, laboratory testing, and stability studies. Greenskybio holds USFDA certification, demonstrating that its manufacturing processes, quality systems, and documentation practices meet the expectations of the US Food and Drug Administration.

4. TGA Certification — Market Access for Australia and the Asia-Pacific Region

The Therapeutic Goods Administration (TGA) is Australia's regulatory authority for therapeutic goods. TGA certification is required for any pharmaceutical product or ingredient entering the Australian market. The TGA conducts rigorous inspections of manufacturing facilities, assessing compliance with GMP standards comparable to those of the EU and US FDA.

For chemical synthesis companies, TGA certification demonstrates that their manufacturing operations meet the high standards expected by one of the world's most respected regulatory bodies. It also facilitates market access across the broader Asia-Pacific region, where many countries recognize TGA approvals. Greenskybio holds TGA certification, enabling its chemical synthesis products to reach pharmaceutical manufacturers in Australia and beyond.

5. MEDSAFE Certification — New Zealand Regulatory Approval

MEDSAFE is the New Zealand Medicines and Medical Devices Safety Authority, responsible for regulating therapeutic products in New Zealand. MEDSAFE certification is another important credential for chemical synthesis companies supplying pharmaceutical-grade ingredients to the New Zealand market.

MEDSAFE's assessment framework is aligned with international GMP standards, and its certification is recognized as a mark of quality and safety. Greenskybio holds MEDSAFE certification, further expanding the geographic reach of its chemical synthesis services and reinforcing its commitment to global regulatory compliance.

6. Good Laboratory Practices (GLP) — Ensuring Reliable Test Data

GLP is a quality system concerned with the organizational process and conditions under which non-clinical laboratory studies are planned, performed, monitored, recorded, reported, and archived. For chemical synthesis companies, GLP compliance is critical for the reliability of analytical testing, impurity profiling, and stability studies that pharmaceutical buyers rely on for regulatory submissions.

GLP ensures that laboratory data is traceable, reproducible, and auditable — principles that are foundational to the ALCOA+ data integrity framework (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available). Greenskybio operates under GLP standards, ensuring that every batch of synthesized compounds is backed by reliable, verifiable laboratory data.

7. Organic and GAP Certifications — For Naturally Derived Synthesized Products

For chemical synthesis companies that also work with naturally derived compounds or bio-based synthesis pathways, organic certification and Good Agricultural Practices (GAP) certification add another layer of credibility. These certifications demonstrate that raw materials are sourced from responsibly managed agricultural operations.

Greenskybio maintains a 5,000 mu GAP-certified organic planting base, cultivating 20 kinds of organic plants and over 200 varieties of herbs. The company also holds organic product certification, ensuring that its naturally derived synthesized compounds meet the strictest purity and sustainability standards.

8. Additional Certifications Worth Considering

Depending on the specific pharmaceutical application, chemical synthesis companies may also benefit from the following certifications:

• ISO 14001 (Environmental Management) — increasingly required by multinational pharmaceutical buyers under their ESG reporting obligations
• ISO 45001 (Occupational Health and Safety) — demonstrates commitment to worker safety in chemical handling environments
• ISO 17025 (Laboratory Competence) — certifies the technical competence of in-house testing laboratories
• ISO 13485 (Medical Devices) — relevant for companies producing combination products or drug-device components
• ICH Q7 — the specific GMP guideline for active pharmaceutical ingredients, harmonized across the EU, US, and Japan

Why Certifications Matter for Chemical Synthesis Buyers

For pharmaceutical companies evaluating potential chemical synthesis partners, certifications are not merely administrative badges — they are risk management tools. A certified supplier has demonstrated that its facilities, processes, and personnel meet internationally recognized standards for quality, safety, and consistency. This translates directly into fewer batch failures, smoother regulatory submissions, and a more reliable supply chain.

Greenskybio, operating as Plant Extract Wholesale, exemplifies the certification profile that pharmaceutical buyers should look for. With ISO 9001, USFDA, TGA, MEDSAFE, SGS GMP, cGMP, GLP, organic, and GAP certifications, the company provides a comprehensive compliance framework that supports pharmaceutical manufacturers across multiple regulated markets.

Conclusion

The certifications required for chemical synthesis in pharmaceutical work extend far beyond a single GMP certificate. A robust compliance portfolio includes WHO GMP or cGMP, ISO 9001, market-specific regulatory approvals such as USFDA, TGA, and MEDSAFE, and laboratory standards such as GLP. For pharmaceutical buyers, partnering with a chemical synthesis company that holds these certifications reduces regulatory risk, ensures product quality, and accelerates time to market.

When evaluating chemical synthesis partners, always verify their certification portfolio. The presence of comprehensive, up-to-date certifications is the most reliable indicator of a supplier's capability to deliver pharmaceutical-grade products consistently and safely.